Definition
Alain Cribier is a French interventional cardiologist renowned for pioneering transcatheter aortic valve implantation (TAVI), also known as transcatheter aortic valve replacement (TAVR). He performed the first successful percutaneous implantation of an aortic valve prosthesis in a human patient in 2002.
Overview
Born in 1947 in France, Cribier studied medicine at the University of Paris and specialized in cardiology. He held academic positions at the University of Paris–Sorbonne and served as director of the cardiology department at the Hôpital Pitié‑Salpêtrière. His research has focused on innovative minimally invasive techniques for treating structural heart disease, particularly aortic stenosis. The "Cribier‑Edwards" valve, the first balloon‑expandable transcatheter valve, bears his name in collaboration with Edwards Lifesciences. Cribier’s work has contributed to the widespread adoption of TAVI, which is now an established therapeutic option for patients with severe aortic stenosis who are at high surgical risk.
Etymology/Origin
- Alain: A French masculine given name derived from the Celtic name “Alain” or the Breton “Alan,” meaning “rock” or “handsome.”
- Cribier: A French surname of uncertain origin; it may be occupational or locational, typical of French naming conventions.
Characteristics
- Education and Training: Medical degree (MD) from the University of Paris; specialized training in cardiology and interventional techniques.
- Professional Roles: Professor of Cardiology, Director of Cardiology Services at major Parisian hospitals, and consultant for medical device companies.
- Key Contributions:
- Development and first human implantation of a percutaneous aortic valve (Cribier‑Edwards valve, 2002).
- Numerous clinical trials establishing safety and efficacy of TAVI in various patient populations.
- Over 300 peer‑reviewed publications and multiple patents related to cardiovascular devices.
- Awards and Honors: Recipient of the European Society of Cardiology’s “Gold Medal,” the “Louis‑Henri de Guise” prize, and honorary memberships in several cardiology societies.
- Impact: His innovations have reduced the need for open‑heart surgery in selected patients, expanded treatment options for aortic stenosis, and influenced the design of subsequent TAVI devices worldwide.
Related Topics
- Transcatheter Aortic Valve Implantation (TAVI/TAVR)
- Aortic Stenosis
- Interventional Cardiology
- Cribier‑Edwards Valve
- Edwards Lifesciences
- Structural Heart Disease
- Minimally Invasive Cardiac Surgery
All information presented is based on verified medical and academic sources.